Florence Lerebours

ScholarGPS® ID: 45266646789386

Affiliation

Institut Curie, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

151

Predicted Citations

5,166

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study (journal article) Duivon, Mylène \| Lequesne, Justine \| Di Meglio, Antonio \| Pradon, Caroline \| Vaz-Luis, Ines \| Martin, Anne-Laure \| Everhard, Sibille \| Broutin, Sophie \| Rigal, Olivier \| Bousrih, Chayma \| ... \| Joly, Florence Breast Cancer Research, volume 26, issue 1 (2024). 10.1186/s13058-024-01850-5 Cited by (1) \| Cite \| Source
Aromatase inhibitor musculoskeletal toxicity (AIMT) in patients (pts) with early breast cancer (EBC): Prevalence, management, and association with non-adherence to AI. (journal article) Lapidari, Pietro \| Lustberg, Maryam B. \| Havas, Julie \| Pagliuca, Martina \| Franzoi, Maria Alice B \| Menvielle, Gwenn \| Pistilli, Barbara \| Jouannaud, Christelle \| Sauterey, Baptiste \| Tredan, Olivier \| ... \| Di Meglio, Antonio Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 12122-12122 (2024). 10.1200/JCO.2024.42.16_suppl.12122 Cite \| Source
TOPOLOGY: A phase II study to evaluate the efficacy and toxicities of PLX038, in patients with locally advanced or metastatic triple-negative breast cancer. (journal article) Cabel, Luc \| Loirat, Delphine \| Martin Babau, Jerome \| Bello, Diana \| Pierga, Jean-Yves \| Lerebours, Florence \| Ezzili, Cyrine \| Berger, Frederique \| Bidard, Francois Clement Journal of Clinical Oncology, volume 42, issue 16_suppl, pages TPS1142-TPS1142 (2024). 10.1200/JCO.2024.42.16_suppl.TPS1142 Cite \| Source
132P Clinico-pathological characteristics, treatments and survival outcomes of patients with high-risk hormone receptor positive early breast cancer (HR+ BC) in French real-world (RW) setting: A study from CANTO cohort (journal article) Giugliano, F. \| Bertaut, A. \| Blanc, J. \| Martin, A-L. \| Gaudin, C. \| Fournier, M. \| Kieffer, A. \| Sauterey, B. \| Levy, C. \| Campone, M. \| ... \| Rassy, E. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103119 Cite \| Source
Mutational landscape of inflammatory breast cancer (journal article) Bertucci, François \| Lerebours, Florence \| Ceccarelli, Michele \| Guille, Arnaud \| Syed, Najeeb \| Finetti, Pascal \| Adélaïde, José \| Van Laere, Steven \| Goncalves, Anthony \| Viens, Patrice \| ... \| Bedognetti, Davide Journal of Translational Medicine, volume 22, issue 1 (2024). 10.1186/s12967-024-05198-4 Cite \| Source
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis (journal article) Vasseur, Antoine \| Cabel, Luc \| Hego, Caroline \| Takka, Wissam \| Trabelsi Grati, Olfa \| Renouf, Benjamin \| Lerebours, Florence \| Loirat, Delphine \| Brain, Etienne \| Cottu, Paul \| ... \| Bidard, François-Clément Oncogene, volume 43, issue 16, pages 1214-1222 (2024). 10.1038/s41388-024-02986-6 Cite \| Source
Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life Experience (journal article) Tison, Thais \| Loap, Pierre \| Arnaud, Emilie \| Cao, Kim \| Bringer, Solene \| Kissel, Manon \| Maaradji, Safia \| Mainguene, Juliette \| Pierga, Jean-Yves \| Lerebours, Florence \| ... \| Kirova, Youlia M. Advances in Radiation Oncology, volume 9, issue 3, pages 101384- (2024). 10.1016/j.adro.2023.101384 Cited by (1) \| Cite \| Source
État de l’art dans le traitement médical adjuvant des cancers du sein précoces RH+/HER2- (journal article) Cottu, Paul \| Lerebours, Florence Innovations & Thérapeutiques en Oncologie, volume 9, issue S1, pages 4-10 (2023). 10.1684/ito.2023.389 Cite \| Source
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer, in real‐life settings (journal article) Hequet, D. \| Hajjaji, N. \| Charafe‐Jauffret, E. \| Boucrauta, A. \| Dalenc, F. \| Nicolai, V. \| Lopez, J. \| Tredan, O. \| Deluche, E. \| Fermeaux, V. \| ... \| Rouzier, R. Cancer Medicine, volume 12, issue 16, pages 16889-16895 (2023). 10.1002/cam4.6315 Cite \| Source
Training and validation of a model predicting clusters of long-term cancer-related behavioral symptoms (CRBS) after breast cancer (BC). (journal article) Pagliuca, Martina \| Havas, Julie \| Lerebours, Florence \| Rigal, Olivier \| Petit, Thierry \| Giacchetti, Sylvie \| Dalenc, Florence \| Wassermann, Johanna \| Arsene, Olivier \| Martin, Anne-Laure \| ... \| Di Meglio, Antonio Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 12087-12087 (2023). 10.1200/JCO.2023.41.16_suppl.12087 Cite \| Source
Alpelisib + endocrine therapy in patients with PIK3CA -mutated, hormone receptor–positive, human epidermal growth factor receptor 2–negative, advanced breast cancer: Analysis of all 3 cohorts of the BYLieve study. (journal article) Chia, Stephen \| Neven, Patrick \| Ciruelos, Eva M \| Lerebours, Florence \| Ruiz-Borrego, Manuel \| Drullinsky, Pamela \| Prat, Aleix \| Park, Yeon Hee \| Juric, Dejan \| Turner, Nicholas C. \| ... \| Rugo, Hope S. Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 1078-1078 (2023). 10.1200/JCO.2023.41.16_suppl.1078 Cited by (6) \| Cite \| Source
No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC (journal article) Grandal, Beatriz \| Aljehani, Ashwaq \| Dumas, Elise \| Daoud, Eric \| Jochum, Floriane \| Gougis, Paul \| Hotton, Judicaël \| Lemoine, Amélie \| Michel, Sophie \| Laas, Enora \| ... \| Hamy, Anne Sophie Cancers, volume 14, issue 13, pages 3080- (2022). 10.3390/cancers14133080 Cite \| Source
Alpelisib (ALP) + endocrine therapy (ET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), PIK3CA -mutated (mut) advanced breast cancer (ABC): Baseline biomarker analysis and progression-fre (journal article) Juric, Dejan \| Rugo, Hope S. \| Chia, Stephen K.L. \| Lerebours, Florence \| Ruiz-Borrego, Manuel \| Drullinsky, Pamela \| Ciruelos, Eva M. \| Neven, Patrick \| Park, Yeon Hee \| Arce, Christina H. \| ... \| Turner, Nicholas C. Journal of Clinical Oncology, volume 40, issue 16_suppl, pages 1018-1018 (2022). 10.1200/JCO.2022.40.16_suppl.1018 Cited by (3) \| Cite \| Source
175P Alpelisib (ALP) + endocrine therapy (ET) in patients (pts) with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC): Subgroup analyses from the BYLieve study (journal article) Cardoso, F. \| Juric, D. \| Lerebours, F. \| Krop, I. \| Ruiz Borrego, M. \| Neven, P. \| Park, Y.H. \| Yardley, D. \| Jhaveri, K. \| Arce, C. \| ... \| Rugo, H.S. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.03.194 Cited by (1) \| Cite \| Source
Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals (journal article) Chalumeau, Clelia \| Carton, Matthieu \| Eeckhoutte, Alexandre \| Ballet, Stelly \| Vincent-Salomon, Anne \| Vuagnat, Perrine \| Bellesoeur, Audrey \| Pierga, Jean-Yves \| Stern, Marc-Henri \| Bidard, Francois-Clement \| Lerebours, Florence Cancers, volume 14, issue 9, pages 2114- (2022). 10.3390/cancers14092114 Cited by (3) \| Cite \| Source
Attitudes and Factors Influencing Contraception Use and Persistence in Premenopausal Women With Early Breast Cancer: Results From the Prospective CANTO Cohort Study (journal article) Lambertini, Matteo \| Massarotti, Claudia \| Havas, Julie \| Pistilli, Barbara \| Martin, Anne-Laure \| Jacquet, Alexandra \| Coutant, Charles \| Coussy, Florence \| Merimeche, Asma Dhaini \| Lerebours, Florence \| ... \| Di Meglio, Antonio SSRN Electronic Journal (2022). 10.2139/ssrn.4003223 Cite \| Source
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer (journal article) Corbaux, Pauline \| Lardy-Cleaud, Audrey \| Alexandre, Marie \| Fontanilles, Maxime \| Lévy, Christelle \| Viansone, Alessandro Adriano \| Mailliez, Audrey \| Debled, Marc \| Goncalves, Anthony \| Le Du, Fanny \| ... \| Bachelot, Thomas Breast Cancer Research and Treatment, volume 191, issue 1, pages 191-207 (2022). 10.1007/s10549-021-06382-6 Cite \| Source
The Challenge of Return to Work after Breast Cancer: The Role of Family Situation, CANTO Cohort (journal article) Caumette, Elsa \| Vaz-Luis, Inès \| Pinto, Sandrine \| Havas, Julie \| Bovagnet, Thomas \| Ruiz de Azua, Garazi \| Di Meglio, Antonio \| Martin, Anne-Laure \| Everhard, Sibille \| Cottu, Paul \| ... \| Menvielle, Gwenn Current Oncology, volume 28, issue 5, pages 3866-3875 (2021). 10.3390/curroncol28050330 Cited by (8) \| Cite \| Source
Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy (journal article) Hours, Alice \| Toussaint, Aullene \| De Castelbajac, Victoire \| Sautter, Camille \| Borghese, Julie \| Frank, Sophie \| Coussy, Florence \| Laas, Enora \| Grandal, Beatriz \| Dumas, Elise \| ... \| Hamy, Anne-Sophie Frontiers in Oncology, volume 11 (2021). 10.3389/fonc.2021.701620 Cited by (2) \| Cite \| Source
125P Cognitive impairment in breast cancer patients up to 18 months after cancer treatments: The French multicentric longitudinal CANTO-Cog cohort substudy (journal article) Lobbedez, F. Joly \| Hardy-Léger, I. \| Arbogast, S. Lefevre \| Rigal, O. \| Le Fel, J. \| Pistilli, B. \| Petrucci, J. \| Lévy, C. \| Capel, A. \| Coutant, C. \| ... \| Lange, M. Annals of Oncology, volume 32 (2021). 10.1016/j.annonc.2021.08.406 Cite \| Source